ewsba.se
Prospect Capital (PSEC) — $0.045 monthly distribution yields 20.1%, supported by 1.4x net investment income coverage.
Prospect Capital rotated portfolio 728 basis points into safer first lien loans, reducing non-accrual assets to 0.7%.
NAV dropped 20.8% year-over-year to $6.21 per share despite funded distributions and positive insider buying signals.
The analyst who called NVIDIA in 2010 just named his top 10 stocks and Prospect Capital wasn't one of them. Get them here FREE.
Prospect Capital (NASDAQ:PSEC) pays a monthly distribution of $0.045 per share, which works out to $0.54 annualized and a yield of roughly 20.1% at a recent share price of almost $3. A yield that fat usually flashes a warning, and the company did cut its monthly payout from $0.06 to $0.045 in late 2024. The question for income investors is whether the new, lower distribution is finally on solid footing.
PSEC is an externally managed Business Development Company that functions as a high-yield income vehicle for retail investors. Income flows from interest on direct loans to middle-market businesses, with smaller contributions from payment-in-kind interest, controlled-affiliate dividends, and real estate held through National Property REIT Corp.
Management has spent the last two years rotating into the safest part of the capital stack. First lien senior secured middle market loans now make up 71% of the portfolio at cost, up 728 basis points since June 2024, while subordinated structured notes have been wound down toward 0.3%. The target borrower is a company with less than $50 million in EBITDA, and software exposure sits at 3% versus a 22% BDC industry average, sidestepping the most crowded corner of private credit.
The cleanest read on dividend safety for a BDC is net investment income (NII) per share against the distribution. In fiscal Q2 2026, PSEC reported NII of $90.89 million, or $0.19 per share, against a quarterly distribution of $0.135. That is roughly 1.4x coverage.
Q1 2026 NII of $0.17 per share covered the same payout about 1.26x and beat the $0.11 consensus. Interest coverage at the BDC level reached 426%, up from 339% the prior quarter.
Credit quality has firmed alongside the rotation. Non-accrual loans came in at 0.7% of total assets, down from a 4% peak in fiscal Q4 2025. Total liabilities fell 49% year over year, and the next institutional bond maturity is $300 million in November 2026, giving management runway to keep grinding through the portfolio without refinancing pressure.
The distribution is funded, but the equity has been bleeding. Net asset value per share dropped to $6.21 from $7.84 a year earlier, and the portfolio company count fell to 91 from 114. Realized investment losses of $141.3 million in Q2 2026 and $308.5 million in Q4 2025 drove the NAV erosion. Annualized current yield on investments has slipped from 9.7% to 9.1% as lower base rates and the rotation into safer first lien paper compress income.
Total return reflects all of that. PSEC has returned negative 8% over the past year and negative 37% over five years on a price basis, even with the fat coupon. One contrarian signal worth weighing: COO M. Grier Eliasek bought 942,800 shares at around $3 on February 11, 2026, roughly $2.75 million of open-market insider buying.
The current $0.045 monthly distribution looks safe through at least the next several quarters. NII covers it with cushion, non-accruals are normalized, leverage is down, and there are no near-term debt walls. The yield premium over the 4.42% 10-year Treasury is real compensation for credit risk. PSEC fits investors who want monthly cash and accept that the principal will keep grinding lower while management finishes repositioning. Anyone counting on capital appreciation alongside the coupon should look elsewhere.
This analyst's 2025 picks are up 106% on average. He just named his top 10 stocks to buy in 2026. Get them here FREE.